AngioDynamics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Shareholders held on October 22, 2013. The filing covers the election of directors, the ratification of the independent auditor, and the advisory vote on executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders approved all three proposals presented at the meeting:
- Election of Directors: Three Class I directors were elected to serve until the 2016 Annual Meeting.
- Jeffrey G. Gold: 28,946,733 votes for; 624,808 withheld; 2,255,443 broker non-votes.
- Kevin J. Gould: 26,487,110 votes for; 3,102,431 withheld; 2,255,443 broker non-votes.
- Dennis S. Meteny: 26,514,556 votes for; 3,074,985 withheld; 2,255,443 broker non-votes.
- Ratification of Auditor: PricewaterhouseCoopers LLP was approved as the independent registered public accounting firm for the fiscal year ending May 31, 2014.
- Votes For: 31,440,180
- Votes Against: 388,835
- Abstentions: 15,969
- Executive Compensation Advisory Vote: The proposal to approve executive compensation policies was approved.
- Votes For: 28,896,516
- Votes Against: 323,401
- Abstentions: 369,624
- Broker Non-Votes: 2,255,443
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of votes cast for each director and proposal.
- Confirm the specific terms of the executive compensation policies approved in the advisory vote.
- Review the full proxy statement for details on the background of the nominated directors and the rationale for the auditor selection.